Peapack-Gladstone Financial Corp’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.69M Sell
51,481
-4,428
-8% -$757K 0.11% 175
2025
Q4
$9.44M Sell
55,909
-1,249
-2% -$203K 0.12% 165
2025
Q3
$8.25M Sell
57,158
-1,271
-2% -$173K 0.11% 173
2025
Q2
$7.39M Sell
58,429
-3,886
-6% -$477K 0.1% 179
2025
Q1
$7.97M Sell
62,315
-1,944
-3% -$264K 0.12% 166
2024
Q4
$8.5M Sell
64,259
-2,252
-3% -$317K 0.12% 161
2024
Q3
$9.68M Sell
66,511
-2,951
-4% -$427K 0.14% 153
2024
Q2
$9.53M Sell
69,462
-5,129
-7% -$685K 0.15% 150
2024
Q1
$10.2M Sell
74,591
-2,248
-3% -$307K 0.16% 143
2023
Q4
$10.4M Sell
76,839
-974
-1% -$119K 0.18% 138
2023
Q3
$9.52M Sell
77,813
-1,042
-1% -$133K 0.18% 137
2023
Q2
$10M Sell
78,855
-2,082
-3% -$270K 0.18% 138
2023
Q1
$10.6M Sell
80,937
-2,610
-3% -$342K 0.2% 126
2022
Q4
$11M Sell
83,547
-2,015
-2% -$260K 0.22% 124
2022
Q3
$10M Buy
85,562
+20,814
+32% +$2.58M 0.2% 121
2022
Q2
$7.62M Sell
64,748
-3,125
-5% -$371K 0.17% 140
2022
Q1
$8.85M Sell
67,873
-1,750
-3% -$228K 0.17% 139
2021
Q4
$10.6M Buy
69,623
+551
+0.8% +$85.3K 0.2% 126
2021
Q3
$11.2M Sell
69,072
-1,951
-3% -$328K 0.23% 114
2021
Q2
$11.6M Sell
71,023
-1,636
-2% -$252K 0.28% 102
2021
Q1
$10.9M Sell
72,659
-1,277
-2% -$203K 0.28% 101
2020
Q4
$11.2M Buy
73,936
+26,195
+55% +$3.74M 0.34% 88
2020
Q3
$6.46M Buy
47,741
+625
+1% +$84.8K 0.23% 105
2020
Q2
$6.44M Sell
47,116
-1,155
-2% -$147K 0.25% 102
2020
Q1
$5.2M Sell
48,271
-1,095
-2% -$126K 0.25% 98
2019
Q4
$5.95M Sell
49,366
-2,703
-5% -$302K 0.24% 100
2019
Q3
$5.18M Sell
52,069
-5,825
-10% -$610K 0.22% 105
2019
Q2
$6.32M Sell
57,894
-1,350
-2% -$144K 0.27% 92
2019
Q1
$6.62M Sell
59,244
-6,850
-10% -$751K 0.3% 91
2018
Q4
$6.37M Sell
66,094
-2,357
-3% -$250K 0.33% 85
2018
Q3
$8.35M Sell
68,451
-2,300
-3% -$271K 0.41% 80
2018
Q2
$7.77M Sell
70,751
-1,563
-2% -$167K 0.41% 79
2018
Q1
$7.72M Buy
72,314
+1,210
+2% +$134K 0.42% 79
2017
Q4
$7.59M Buy
71,104
+2,815
+4% +$301K 0.41% 80
2017
Q3
$7.59M Sell
68,289
-2,094
-3% -$224K 0.44% 75
2017
Q2
$7.27M Sell
70,383
-1,980
-3% -$195K 0.43% 78
2017
Q1
$7.07M Sell
72,363
-4,410
-6% -$422K 0.44% 74
2016
Q4
$6.79M Sell
76,773
-33,801
-31% -$3.08M 0.44% 75
2016
Q3
$10.7M Sell
110,574
-32,775
-23% -$3.12M 0.71% 53
2016
Q2
$12.3M Sell
143,349
-52,920
-27% -$4.75M 0.85% 39
2016
Q1
$17.1M Buy
196,269
+22,032
+13% +$1.97M 1.2% 22
2015
Q4
$19.6M Buy
174,237
+21,435
+14% +$2.33M 1.38% 16
2015
Q3
$15.4M Buy
152,802
+11,730
+8% +$1.41M 1.16% 24
2015
Q2
$17.4M Buy
141,072
+4,404
+3% +$527K 1.22% 24
2015
Q1
$15.6M Buy
136,668
+342
+0.3% +$37.7K 1.08% 27
2014
Q4
$13.8M Buy
136,326
+14,031
+11% +$1.36M 0.97% 31
2014
Q3
$11.2M Sell
122,295
-336
-0.3% -$29.5K 0.83% 37
2014
Q2
$10.5M Buy
122,631
+3,522
+3% +$277K 0.79% 41
2014
Q1
$9.39M Buy
119,109
+3,150
+3% +$262K 0.74% 42
2013
Q4
$8.78M Buy
115,959
+3,795
+3% +$269K 0.71% 42
2013
Q3
$7.84M Buy
112,164
+9,183
+9% +$602K 0.69% 45
2013
Q2
$5.97M Buy
+102,981
New +$5.95M 0.55% 58

Other funds holding IBB

Peapack-Gladstone Financial Corp's IBB Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp reduced its iShares Biotechnology ETF (IBB) stake by 7.9% in Q1 2026, selling an estimated $757K and leaving 51,481 shares worth $8.69M. The position accounts for 0.11% of the portfolio, ranked #175.

Peapack-Gladstone Financial Corp first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.6M in Q4 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 51,481 shares of iShares Biotechnology ETF worth $8.69M as of Q1 2026.
  • Peapack-Gladstone Financial Corp sold 4,428 iShares Biotechnology ETF shares in Q1 2026, an estimated $757K.
  • iShares Biotechnology ETF made up 0.11% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #175 holding.
  • Peapack-Gladstone Financial Corp first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Peapack-Gladstone Financial Corp's iShares Biotechnology ETF position peaked at $19.6M in Q4 2015.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.